RESUMO
Tension between the Trump administration and its public health officials burst into the open this week, as President Donald Trump openly criticised his top infectious disease specialist, Anthony Fauci, for testifying in Congress against the reopening of states that have not met the administration's published criteria for ending their lockdowns.1 Dozens of mostly Republican controlled states are lifting restrictions despite failing grades on metrics such as new daily infections and percentage of positive test results. Maskless revellers filled bars across Wisconsin on the night of 13 May, as the state's conservative dominated Supreme Court struck down a lockdown imposed by Democratic governor Tony Evers. White House, April 16, 2020. https://www.whitehouse.gov/openingamerica/ 2 Dyer O. Covid-19: Trump says added deaths are necessary price for reopening US businesses.
Assuntos
COVID-19 , Cirurgiões , Humanos , COVID-19/prevenção & controle , Florida/epidemiologia , Universidades , VacinaçãoRESUMO
The Food and Drug Administration (FDA) authorised updated boosters from Pfizer BioNTech and from Moderna on 31 August, and an expert advisory committee convened the next day by the Centers for Disease Control and Prevention (CDC) voted 13-1 to recommend their use. A projection shown to the experts estimated that waiting to roll out the new boosters until November, when more human data will be available could have resulted in 9700 more deaths and 137 000 more hospital admissions.1 Canada approves older omicron booster Health Canada on 1 September approved for adults Moderna’s bivalent booster that targets the omicron BA.1 variant. BA.1 disappeared from circulation in May, but Canada’s National Advisory Committee on Immunization said the new booster will generate a significantly more effective neutralising antibody response against BA.4 and BA.5 than the original Moderna vaccine.